Views | |
---|---|
The ...(legacy) | 295 |
The ... | 196 |
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
The ... | 7 | 5 | 5 | 6 | 5 | 6 | 6 |
Views | |
---|---|
The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice._A cluster randomised controlled trial and qualitative investigation.pdf(legacy) | 216 |
The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice._A cluster randomised controlled trial and qualitative investigation.pdf | 63 |
The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation.pdf(legacy) | 1 |
Views | |
---|---|
Australia | 169 |
United States | 137 |
New Zealand | 49 |
United Kingdom | 30 |
China | 18 |
Ukraine | 17 |
Germany | 10 |
France | 9 |
AP | 3 |
Ireland | 3 |
Views | |
---|---|
Sydney | 169 |
Wellington | 44 |
Fairfield | 26 |
Alexandria | 17 |
Kiev | 17 |
Indianapolis | 12 |
Wilmington | 9 |
Beijing | 6 |
Cambridge | 6 |
Kiez | 6 |